Hiromitsu Kumada Selected Research

Hiromitsu Kumada Research Topics

Disease

124	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 01/2002
113	Infections 10/2022 - 01/2002
92	Chronic Hepatitis C 10/2022 - 01/2002
76	Fibrosis (Cirrhosis) 12/2022 - 01/2002
71	Chronic Hepatitis B 10/2023 - 01/2002
42	Liver Cirrhosis (Hepatic Cirrhosis) 09/2021 - 01/2002
40	Neoplasms (Cancer) 01/2023 - 01/2003
35	Hepatitis 05/2014 - 01/2002
28	Liver Diseases (Liver Disease) 01/2024 - 01/2002
24	Hepatitis B 01/2022 - 01/2002
23	Hepatitis C 07/2018 - 09/2005
20	Non-alcoholic Fatty Liver Disease 07/2023 - 01/2009
20	Chronic Hepatitis (Chronic Active Hepatitis) 03/2014 - 01/2002
16	Liver Neoplasms (Liver Cancer) 07/2023 - 07/2006
14	Anemia 01/2017 - 07/2004
13	Carcinogenesis 01/2014 - 01/2003
11	Diabetes Mellitus 07/2023 - 07/2006
11	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2009
11	Body Weight (Weight, Body) 01/2021 - 10/2007
7	Disease Progression 09/2023 - 01/2004
7	Virus Diseases (Viral Diseases) 04/2021 - 04/2003
6	Headache (Headaches) 10/2016 - 03/2012
6	Persistent Infection 10/2013 - 05/2004
5	Hypertension (High Blood Pressure) 12/2023 - 09/2009
5	Fever (Fevers) 10/2022 - 03/2012
5	Insulin Resistance 01/2022 - 06/2009
5	Viremia 01/2017 - 01/2007
4	Hepatic Encephalopathy 12/2023 - 10/2004
4	Inflammation (Inflammations) 04/2022 - 01/2012
4	Pruritus (Itching) 09/2018 - 10/2016
4	Diarrhea 04/2016 - 03/2012
3	Fatty Liver 04/2022 - 09/2009

Drug/Important Bio-Agent (IBA)

110	InterferonsIBA 12/2020 - 01/2002
78	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 01/2002
45	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2003
45	Lamivudine (Epivir)FDA Link 05/2017 - 01/2002
37	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2003
31	Hepatitis B e AntigensIBA 01/2024 - 01/2002
28	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 02/2002
21	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2023 - 01/2002
21	daclatasvirIBA 01/2020 - 03/2012
21	Alanine Transaminase (SGPT)IBA 09/2017 - 01/2003
19	entecavir FDA Link 01/2022 - 06/2007
18	lenvatinibIBA 12/2023 - 03/2016
17	AntigensIBA 01/2022 - 01/2002
16	asunaprevirIBA 01/2020 - 03/2012
15	telaprevirIBA 02/2018 - 01/2010
14	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2020 - 01/2003
14	Transaminases (Aminotransferases)IBA 02/2015 - 01/2003
13	Amino Acids FDA Link 09/2015 - 08/2008
11	Protease Inhibitors (Protease Inhibitor)IBA 12/2022 - 01/2010
11	Proteins (Proteins, Gene)FDA Link 10/2022 - 03/2006
11	Serum AlbuminIBA 10/2017 - 07/2005
10	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2023 - 08/2008
10	BilirubinIBA 10/2017 - 01/2003
9	glecaprevir and pibrentasvirIBA 12/2022 - 01/2018
9	Biomarkers (Surrogate Marker)IBA 04/2022 - 12/2007
9	miriplatinIBA 02/2018 - 01/2011
9	Interferon-alpha (Interferon Alfa)IBA 05/2014 - 02/2002
8	adefovir dipivoxil (Hepsera)FDA Link 06/2014 - 01/2004
7	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 03/2015 - 01/2006
7	Interferon-betaIBA 01/2011 - 01/2008
6	Hemoglobins (Hemoglobin)IBA 07/2023 - 11/2004
6	lipoarabinomannan (LAM)IBA 05/2017 - 12/2007
6	AlbuminsIBA 02/2015 - 01/2009
6	adefovirIBA 06/2014 - 01/2004
5	Tenofovir (Viread)FDA Link 12/2021 - 01/2014
5	Fetal Proteins (Fetoprotein)IBA 04/2021 - 09/2013
5	ombitasvirIBA 04/2018 - 05/2015
5	paritaprevirIBA 04/2018 - 05/2015
5	Ritonavir (Norvir)FDA Link 04/2018 - 05/2015
5	NucleosidesIBA 05/2017 - 06/2007
5	PlatinumIBA 03/2013 - 04/2009
4	Cell-Free Nucleic AcidsIBA 01/2023 - 12/2020
4	SofosbuvirIBA 10/2022 - 01/2017
4	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 02/2002
4	NucleotidesIBA 02/2022 - 09/2004
4	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2017
4	Sorafenib (BAY 43-9006)FDA Link 02/2021 - 09/2011
4	Glucose (Dextrose)FDA LinkGeneric 02/2020 - 06/2012
4	8- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA 01/2020 - 03/2017
4	grazoprevirIBA 01/2020 - 04/2017
4	elbasvirIBA 01/2020 - 04/2017
4	P-300IBA 08/2019 - 01/2018
4	SimeprevirIBA 01/2017 - 05/2014
4	Branched-Chain Amino AcidsIBA 05/2013 - 07/2005
4	Aspartic Acid (Aspartate)FDA Link 04/2010 - 05/2004
3	Tumor Biomarkers (Tumor Markers)IBA 04/2022 - 01/2008
3	CanagliflozinIBA 01/2022 - 05/2019
3	Circular DNAIBA 01/2022 - 01/2009
3	Surface Antigens (Surface Antigen)IBA 01/2022 - 12/2002
3	Peptides (Polypeptides)IBA 09/2021 - 09/2008

Therapy/Procedure

189	Therapeutics 12/2023 - 01/2002
19	Radiofrequency Ablation 02/2019 - 01/2002
10	Drug Tapering 01/2017 - 07/2004
9	Hepatectomy 10/2020 - 12/2013
8	Drug Therapy (Chemotherapy) 09/2023 - 11/2011
6	Aftercare (After-Treatment) 02/2021 - 12/2006
5	Retreatment 03/2019 - 04/2003
4	Duration of Therapy 01/2018 - 01/2010